X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (406) 406
oncology (287) 287
male (284) 284
middle aged (220) 220
aged (219) 219
cancer (215) 215
female (201) 201
urology & nephrology (164) 164
carcinoma, renal cell - drug therapy (143) 143
kidney neoplasms - drug therapy (138) 138
survival (131) 131
urology (130) 130
care and treatment (113) 113
kidney neoplasms - pathology (107) 107
sunitinib (107) 107
treatment outcome (106) 106
carcinoma, renal cell (105) 105
metastasis (105) 105
adult (103) 103
renal cell carcinoma (98) 98
prognosis (96) 96
aged, 80 and over (91) 91
antineoplastic agents - therapeutic use (83) 83
risk factors (79) 79
retrospective studies (76) 76
prostate cancer (75) 75
carcinoma, renal cell - pathology (71) 71
abridged index medicus (70) 70
interferon-alpha (68) 68
disease-free survival (67) 67
hematology, oncology and palliative medicine (66) 66
analysis (64) 64
carcinoma (59) 59
neoplasm metastasis (58) 58
tumors (58) 58
carcinoma, renal cell - mortality (56) 56
everolimus (56) 56
health aspects (54) 54
kidney cancer (54) 54
therapy (54) 54
kidney neoplasms - mortality (52) 52
targeted therapy (51) 51
bevacizumab (50) 50
carcinoma, renal cell - genetics (50) 50
immunotherapy (50) 50
research (50) 50
sorafenib (50) 50
kidney neoplasms - genetics (48) 48
neoplasm staging (48) 48
risk (48) 48
vascular endothelial growth factor (48) 48
carcinoma, renal cell - secondary (46) 46
mortality (46) 46
chemotherapy (44) 44
medical colleges (44) 44
clear cell-type renal cell carcinoma (42) 42
patients (42) 42
antineoplastic combined chemotherapy protocols - therapeutic use (41) 41
patient outcomes (41) 41
survival analysis (38) 38
kaplan-meier estimate (36) 36
men (36) 36
vascular endothelial growth factor a - antagonists & inhibitors (36) 36
mutation (35) 35
trial (35) 35
molecular targeted therapy (34) 34
outcomes (34) 34
proportional hazards models (34) 34
radical prostatectomy (34) 34
survival rate (34) 34
metastases (33) 33
diagnosis (32) 32
risk assessment (32) 32
indoles - therapeutic use (31) 31
prostatic neoplasms - therapy (31) 31
pyrroles - therapeutic use (31) 31
usage (31) 31
double-blind (30) 30
radiotherapy (30) 30
angiogenesis inhibitors - therapeutic use (29) 29
antineoplastic agents - adverse effects (29) 29
expression (29) 29
kidney neoplasms - metabolism (29) 29
protein kinase inhibitors - therapeutic use (29) 29
time factors (29) 29
antineoplastic agents (28) 28
databases, factual (28) 28
drug therapy (28) 28
follow-up studies (28) 28
open-label (28) 28
pazopanib (28) 28
prostatic neoplasms - pathology (28) 28
seer program (28) 28
carcinoma, renal cell - metabolism (27) 27
medicine, general & internal (27) 27
randomized controlled trials as topic (27) 27
bladder cancer (26) 26
clinical trials (26) 26
antimitotic agents (25) 25
efficacy (25) 25
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2019, Volume 380, Issue 12, pp. 1103 - 1115
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 14, pp. 1277 - 1290
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 917 - 927
Journal Article
Nature communications, ISSN 2041-1723, 2019, Volume 10, Issue 1, pp. 1617 - 13
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10032, pp. 2008 - 2016
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 293 - 300
Journal Article
Cell reports (Cambridge), ISSN 2211-1247, 2016, Volume 14, Issue 10, pp. 2476 - 2489
Journal Article